393 related articles for article (PubMed ID: 25490427)
1. Cancer nanoimmunotherapy using advanced pharmaceutical nanotechnology.
Li W; Wei H; Li H; Gao J; Feng SS; Guo Y
Nanomedicine (Lond); 2014 Nov; 9(16):2587-605. PubMed ID: 25490427
[TBL] [Abstract][Full Text] [Related]
2. Nano polymeric carrier fabrication technologies for advanced antitumor therapy.
Li W; Zhao M; Ke C; Zhang G; Zhang L; Li H; Zhang F; Sun Y; Dai J; Wang H; Guo Y
Biomed Res Int; 2013; 2013():305089. PubMed ID: 24369011
[TBL] [Abstract][Full Text] [Related]
3. [Nanomedicine: application of nanotechnology in medicine. Opportunities in neuropsychiatry].
Szebeni J
Neuropsychopharmacol Hung; 2011 Mar; 13(1):15-24. PubMed ID: 21451188
[TBL] [Abstract][Full Text] [Related]
4. Nanotherapeutics for the Treatment of Cancer and Arthritis.
Patel P; Meghani N; Kansara K; Kumar A
Curr Drug Metab; 2019; 20(6):430-445. PubMed ID: 30479211
[TBL] [Abstract][Full Text] [Related]
5. Application of nanotechnology in circumventing immunotolerance.
Ma Y; Shen Y; Zhu B; Li D; Liu J
Pharmazie; 2020 Oct; 75(10):470-477. PubMed ID: 33305719
[TBL] [Abstract][Full Text] [Related]
6. Trends in Nanomedicines for Cancer Treatment.
do Nascimento T; Todeschini AR; Santos-Oliveira R; de Souza de Bustamante Monteiro MS; de Souza VT; Ricci-Júnior E
Curr Pharm Des; 2020; 26(29):3579-3600. PubMed ID: 32186271
[TBL] [Abstract][Full Text] [Related]
7. The finely regulating well-defined functional polymeric nanocarriers for anti-tumor immunotherapy.
Li W; Zhang L; Zhang G; Wei H; Zhao M; Li H; Guo S; Gao J; Kou G; Li B; Dai J; Wang H; Guo Y
Mini Rev Med Chem; 2013 Apr; 13(5):643-52. PubMed ID: 23469780
[TBL] [Abstract][Full Text] [Related]
8. Nanoimmunotherapy: application of nanotechnology for sustained and targeted delivery of antigens to dendritic cells.
Zhang Z; Guo Y; Feng SS
Nanomedicine (Lond); 2012 Jan; 7(1):1-4. PubMed ID: 22191772
[No Abstract] [Full Text] [Related]
9. Nanoparticle-Based Nanomedicines to Promote Cancer Immunotherapy: Recent Advances and Future Directions.
Liu J; Zhang R; Xu ZP
Small; 2019 Aug; 15(32):e1900262. PubMed ID: 30908864
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticle-based immunotherapy for cancer.
Shao K; Singha S; Clemente-Casares X; Tsai S; Yang Y; Santamaria P
ACS Nano; 2015 Jan; 9(1):16-30. PubMed ID: 25469470
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticle-based strategies for cancer immunotherapy and immunodiagnostics.
Grimaldi AM; Incoronato M; Salvatore M; Soricelli A
Nanomedicine (Lond); 2017 Oct; 12(19):2349-2365. PubMed ID: 28868980
[TBL] [Abstract][Full Text] [Related]
12. Nanotechnology platforms for cancer immunotherapy.
Yang Z; Ma Y; Zhao H; Yuan Y; Kim BYS
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1590. PubMed ID: 31696664
[TBL] [Abstract][Full Text] [Related]
13. Nanoscale artificial antigen presenting cells for cancer immunotherapy.
Rhodes KR; Green JJ
Mol Immunol; 2018 Jun; 98():13-18. PubMed ID: 29525074
[TBL] [Abstract][Full Text] [Related]
14. Regulation of cancer-immunity cycle and tumor microenvironment by nanobiomaterials to enhance tumor immunotherapy.
Yang J; Zhang C
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jul; 12(4):e1612. PubMed ID: 32114718
[TBL] [Abstract][Full Text] [Related]
15. Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies.
Klippstein R; Pozo D
Nanomedicine; 2010 Aug; 6(4):523-9. PubMed ID: 20085824
[TBL] [Abstract][Full Text] [Related]
16. Anti-Cancer Nanomedicines: A Revolution of Tumor Immunotherapy.
Li W; Peng A; Wu H; Quan Y; Li Y; Lu L; Cui M
Front Immunol; 2020; 11():601497. PubMed ID: 33408716
[TBL] [Abstract][Full Text] [Related]
17. Antibody-targeted nanoparticles for cancer therapy.
Fay F; Scott CJ
Immunotherapy; 2011 Mar; 3(3):381-94. PubMed ID: 21395380
[TBL] [Abstract][Full Text] [Related]
18. Nanomedicines Targeting the Tumor Microenvironment.
Tong R; Langer R
Cancer J; 2015; 21(4):314-21. PubMed ID: 26222084
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticle-Based Phototriggered Cancer Immunotherapy and Its Domino Effect in the Tumor Microenvironment.
Rajendrakumar SK; Uthaman S; Cho CS; Park IK
Biomacromolecules; 2018 Jun; 19(6):1869-1887. PubMed ID: 29677439
[TBL] [Abstract][Full Text] [Related]
20. Nanotherapeutics in oral and parenteral drug delivery: Key learnings and future outlooks as we think small.
Tyagi P; Subramony JA
J Control Release; 2018 Feb; 272():159-168. PubMed ID: 29355619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]